The Department of Pharmaceuticals (DoP) has notified the Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) with an outlay of Rs. 5,000 crore to support Research and development (R&D) and innovation in pharma, medical devices and animal health segments.
About the scheme:
The scheme has two components comprising strengthening of research infrastructure through establishment of seven National Institutes of Pharmaceutical Education & Research (NIPERs) as Centres of Excellence (CoEs) in specific specialisations and promotion of research in Pharma-MedTech sector by providing financial assistance for research in six priority areas –
? New chemical and biological entities, and natural products;
? Complex generics and biosimilars;
? Precision medicines; medical devices;
? Orphan drugs; and
? Drug development for antimicrobial resistance
The Scheme proposes establishment of CoEs in the seven existing NIPERs at Mohali, Ahmedabad, Hyderabad, Guwahati, Kolkata, Hajipur and Raebareli at a tentative cost of Rs. 700 crore over a
period of five years.
? This will help in building specifi c research capacities in the identifi ed priority areas in a focused time bound programme, tapping industry-academia linkage.
? The CoEs will strengthen the research infrastructure in Pharma-MedTech sectors in the country by providing advanced facilities to conduct research and will also help in nurturing talent pool by promoting industry academia linkage.
? Under the second component of promotion of research in pharma and MedTech sector, the financial assistance will be provided in three categories.
? In the first category (BI), nine established pharma companies may be selected to carry out research in six priority areas with academic collaboration in government institute of national repute.
Verifying, please be patient.
